KSKelsey Sharrad

Kelsey Sharrad

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kelsey Sharrad has a total of 61 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Training health professionals in smoking cessation

    by Kelsey J Sharrad, Kristin V Carson-Chahhoud, Marjolein Ea Verbiest, Sarah Greenslade, Thomas Parkhouse, Willem Jj Assendelft, Mathilde R Crone, Jonathan Livingstone-Banks

    Rationale Cigarette smoking is one of the leading causes of preventable death worldwide. There is good evidence that brief interventions by health professionals can increase smoking cessation attempts. However, as new studies become available, the effectiveness of these training programmes needs to be re‐assessed to inform public policy, clinical care, and guideline recommendations. This is an update of a Cochrane review first published in 2000, and previously updated in 2012. Objectives To assess the effectiveness of training healthcare professionals to deliver smoking cessation interventions to their patients, and to assess the effects of training characteristics (such as content, setting, delivery, and intensity). Search methods We searched the following databases from inception to August 2024: Cochrane Central Register of Controlled Trials (CENTRAL); MEDLINE; Embase; PsycINFO; ClinicalTrials.gov (through CENTRAL); and the World Health Organization International Clinical Trials Registry Platform (through CENTRAL). We also searched the references of eligible studies. Eligibility criteria We included randomised trials in which the intervention was training of healthcare professionals in smoking cessation. We considered trials for inclusion if they reported outcomes for patient smoking at least six months after the intervention. Process outcomes needed to be reported. However, we excluded trials that reported effects only on process outcomes and not smoking behaviour. Outcomes The critical outcome measure was abstinence from smoking six months or more after baseline, using the strictest measure of abstinence available at the longest follow‐up. Prolonged or continuous abstinence was preferred over point prevalence. Our important outcome was the number of participants who made a quit attempt. Risk of bias Working independently, two review authors evaluated the risk of bias using the Cochrane RoB 1 tool, following guidance from the Cochrane Tobacco Addiction Group. Synthesis methods Working independently, two review authors extracted information about the characteristics of each included study (i.e. interventions, participants, outcomes, and methods). We pooled studies using random‐effects meta‐analysis where possible and otherwise summarised findings using narrative synthesis in text and tables. We used the GRADE framework to assess the certainty of the evidence. Included studies We included 29 studies in the review, published between 1989 and 2024. Together, the studies provided training for over 4030 health professionals, and data for 38,178 participants. We assessed 10 studies to have an overall low risk of bias, 17 an unclear risk, and two to have an overall high risk of bias. Synthesis of results Sixteen studies compared training of healthcare professionals in smoking cessation to no training, and assessed the effect on the number of participants abstinent at longest follow‐up. High‐certainty evidence indicates that smoking cessation training for healthcare professionals increases patient smoking cessation compared with no training (risk ratio (RR) 1.34, 95% confidence interval (CI) 1.08 to 1.67; I2 = 48%; 16 studies, 16,513 participants). We conducted three subgroup analyses to test the effect of specific potential sources of heterogeneity: training intensity, type of healthcare professional trained, and treatment recommended in the training; none found evidence of between‐group heterogeneity. Four studies assessed the effect of high‐intensity training for healthcare professionals on the number of participants abstinent at longest follow‐up compared with lower‐intensity training. The evidence suggests that higher‐intensity training may increase smoking cessation compared with lower‐intensity training, though confidence intervals were wide and included the potential for no benefit (RR 1.64, 95% CI 0.86 to 3.12; I2 = 54%; 4 studies, 1151 participants; low‐certainty evidence). Three studies assessed the impact of adjuncts to training on the number of participants abstinent at longest follow‐up. We found low‐certainty evidence that when the healthcare professionals treating them are trained in smoking cessation, more people may quit when also provided with nicotine replacement therapy (RR 1.64, 95% CI 0.72 to 3.71; I2 = 69%; 2 studies, 1892 participants), and very low‐certainty evidence that providing prompts to healthcare professionals in addition to smoking cessation training may help more people to quit (RR 1.37, 95% CI 0.69 to 2.70; I2 = 66%; 3 studies, 2429 participants). However, in both cases, confidence intervals were wide and included the potential for no benefit. Authors' conclusions High‐certainty evidence supports the effectiveness of training health professionals in smoking cessation when compared with no training. Multi‐component investigations incorporating new pharmacological interventions for smoking cessation (such as varenicline and bupropion) or other cessation aids alongside physician training should be considered to determine if any additional benefit in long‐term abstinence can be obtained. Funding Production of this review was supported by PhD scholarship funding from the University of Adelaide and co‐funded by Houd Research Group, awarded to KS. Registration This review was first published outside of Cochrane in 1994 and subsequently updated as a Cochrane review in 2000 (DOI: 10.1002/14651858.CD000214) and 2012 (DOI: 10.1002/14651858.CD000214.pub2). No protocol was published or registered.


  • Open Access

    Developing novel smoking cessation resources for Aboriginal people who smoke tobacco and their healthcare providers: a mixed methods study

    by Kelsey Sharrad, Sasha Stewart, Nick Marlow, Alyson J. Crozier, Ian Gwilt, Adrian Esterman, Gillian Gould, Antony Veale, Alwin Chong, Haydyn Bromley, et al.

    Introduction: Many health professionals (HPs) are reluctant to offer smoking cessation advice to Aboriginal Australians who smoke; suggesting a need for better education to improve HP skills and knowledge to increase confidence. Previous studies exploring culturally relevant smoking cessation training for HPs have been effective among HPs working with Aboriginal Australians. Thus, identifying mechanisms to increase accessibility of these programs is an important public health issue. Augmented reality (AR) has the potential to enhance digital health interventions, and is effective and acceptable across a range of fields. Under the guidance of an Aboriginal advisory group, two sets of resources were developed; i) patient education and cessation resources for use by Aboriginal people who smoke, and ii) HP resources providing brief education to support Aboriginal patients who smoke. The aim of this study was to explore the acceptability of, and iteratively co-design these resources with HPs through qualitative interviews and questionnaires. Methods: HPs were recruited from two South Australian public hospitals between August 2020 and June 2021. One-on-one interviews were conducted with n=18 HPs, with transcripts coded using the Theoretical Framework of Acceptability (TFA). Results: Participants found that the AR-embedded patient resources provided engaging and relatable quit smoking support. The HP resources based on brief counselling techniques were considered a helpful reminder to prompt a smoking cessation conversation with Aboriginal patients. Conclusion: These resources were considered acceptable by HPs who treat Aboriginal Australians who smoke, and may serve as a useful adjunct to HP training sessions.

  • Open Access

    Financial Incentives for Substance Abstinence: A Systematic Review and Meta-analysis

    by Damon Phillips-Chantelois, Kelsey Sharrad, Shagufta Perveen, Tahlia Grammatopoulos, Nawal Usmani, Karen Szumlinski, Kristin Carson-Chahhoud

    Introduction: Substance use disorder (SUD) increased by 45% globally in the past 10 years, representing one of the largest increases in risk factors for disease. Financial incentives (FI) are a promising tool to promote health behavior change, including substance abstinence. We aim to address a 10-year gap in the evidence and identify key characteristics for optimal treatment. Aims and Methods: A meta-analysis of randomized controlled trials (RCTs) was undertaken per Cochrane guidelines and the PRISMA 2020 checklist. Medline, PsycINFO, and EMBASE were searched up to September 11, 2024. Included studies offered FI to substance users in exchange for substance abstinence compared to an alternative intervention control. The primary outcome extracted was substance abstinence at the latest follow-up. Secondary outcomes such as cost-effectiveness, adverse events, and motivational assessments were also extracted. The risk of bias was analyzed using the RoB 1 tool. Results: Of 5042 studies identified, 246 were shortlisted for full-text review and included 39 RCTs (N = 27 845) for meta-analysis. SUD categories spanning nicotine (n = 30, odds ratios [OR] = 1.83; 95% CI = 1.65 to 2.03, p < .001), alcohol (n = 3, OR = 4.69, 95% CI = 1.59 to 13.86, p = .005), stimulants (n = 2, OR = 3.52; 95% CI = 0.36 to 34.18, p = .28), and polydrug (n = 2, OR = 3.11, 95% CI = 0.53 to 18.25, p = .21) were meta-analyzed for improving abstinence rates. Cannabis and opioid subgroups could not be meta-analyzed. Overall effectiveness was significant for FI improving substance abstinence rates (OR = 1.93, 95% CI = 1.66 to 2.24, p < .001) with continued significance through 12-month or longer follow-ups (OR = 1.78; 95% CI = 1.50 to 2.12, p < .001). Conclusions: Findings from this meta-analysis suggest that FI are an effective tool for increasing substance abstinence, particularly nicotine and alcohol; however, future research is recommended for other substances such as stimulants and opioids. Implications: This systematic review and meta-analysis exploring the use of FI for SUDs provides the first update on trends in this field since 2014 and the first meta-analysis since 2006. Notably, this review challenges the concerns of sustainability and effects on motivation which have withheld the clinical application of FI for SUDs.


  • Open Access

    A gender breakdown of unexpected benefits generated by work from home in STEM fields − A qualitative analysis of the WiMPBME Task Group survey

    by Eva Bezak, Kelsey J. Sharrad, Loredana G. Marcu, Magdalena Stoeva, Lenka Lhotska, Gilda Barabino, Fatimah Ibrahim, Sierin Lim, Eleni Kaldoudi, Ana Maria Marques da Silva, et al.


  • Open Access

    Renewing the Australian asthma agenda: lessons from the Finnish 10-year Asthma Program

    by Kristin Carson-Chahhoud, Kelsey Sharrad, Malcolm Brinn, Rose Bell, Tari Haahtela

    The Finnish Asthma Program, which ran between 1994 and 2004, has long been heralded as a benchmark of success in how to improve management and reduce asthma-related health service utilization. In Au


  • Psychological interventions for asthma in children and adolescents

    by Kelsey J Sharrad, Olatokunbo Sanwo, Sofia Cuevas-Asturias, Kayleigh M Kew, Kristin V Carson-Chahhoud, Katharine C Pike

    Background Rates of asthma are high in children and adolescents, and young people with asthma generally report poorer health outcomes than those without asthma. Young people with asthma experience a range of challenges that may contribute to psychological distress. This is compounded by the social, psychological, and developmental challenges experienced by all people during this life stage. Psychological interventions (such as behavioural therapies or cognitive therapies) have the potential to reduce psychological distress and thus improve behavioural outcomes such as self‐efficacy and medication adherence. In turn, this may reduce medical contacts and asthma attacks. Objectives To determine the efficacy of psychological interventions for modifying health and behavioural outcomes in children with asthma, compared with usual treatment, treatment with no psychological component, or no treatment. Search methods We searched the Cochrane Airways Group Specialised Register (including CENTRAL, CRS, MEDLINE, Embase, PsycINFO, CINAHL EBSCO, AMED EBSCO), proceedings of major respiratory conferences, reference lists of included studies, and online clinical databases. The most recent search was conducted on 22 August 2022. Selection criteria We included randomised controlled trials (RCTs) comparing psychological interventions of any duration with usual care, active controls, or a waiting‐list control in male and female children and adolescents (aged five to 18 years) with asthma. Data collection and analysis We used standard Cochrane methods. Our primary outcomes were 1. symptoms of anxiety and depression, 2. medical contacts, and 3. asthma attacks. Our secondary outcomes were 1. self‐reported asthma symptoms, 2. medication use, 3. quality of life, and 4. adverse events/side effects. Main results We included 24 studies (1639 participants) published between 1978 and 2021. Eleven studies were set in the USA, five in China, two in Sweden, three in Iran, and one each in the Netherlands, UK, and Germany. Participants' asthma severity ranged from mild to severe. Three studies included primary school‐aged participants (five to 12 years), two included secondary school‐aged participants (13 to 18 years), and 18 included both age groups, while one study was unclear on the age ranges. Durations of interventions ranged from three days to eight months. One intervention was conducted online and the rest were face‐to‐face. Meta‐analysis was not possible due to clinical heterogeneity (interventions, populations, outcome tools and definitions, and length of follow‐up). We tabulated and summarised the results narratively with reference to direction, magnitude, and certainty of effects. The certainty of the evidence was very low for all outcomes. A lack of information about scale metrics and minimal clinically important differences for the scales used to measure anxiety, depression, asthma symptoms, medication use, and quality of life made it difficult to judge clinical significance. Primary outcomes Four studies (327 participants) reported beneficial or mixed effects of psychological interventions versus controls for symptoms of anxiety, and one found little to no difference between groups (104 participants). Two studies (166 participants) that evaluated symptoms of depression both reported benefits of psychological interventions compared to controls. Three small studies (92 participants) reported a reduction in medical contacts, but two larger studies (544 participants) found little or no difference between groups in this outcome. Two studies (107 participants) found that the intervention had an important beneficial effect on number of asthma attacks, and one small study (22 participants) found little or no effect of the intervention for this outcome. Secondary outcomes Eleven studies (720 participants) assessed asthma symptoms; four (322 participants) reported beneficial effects of the intervention compared to control, five (257 participants) reported mixed or unclear findings, and two (131 participants) found little or no difference between groups. Eight studies (822 participants) reported a variety of medication use measures; six of these studies (670 participants) found a positive effect of the intervention versus control, and the other two (152 participants) found little or no difference between the groups. Across six studies (653 participants) reporting measures of quality of life, the largest three (522 participants) found little or no difference between the groups. Where findings were positive or mixed, there was evidence of selective reporting (2 studies, 131 participants). No studies provided data related to adverse effects. Authors' conclusions Most studies that reported symptoms of anxiety, depression, asthma attacks, asthma symptoms, and medication use found a positive effect of psychological interventions versus control on at least one measure. However, some findings were mixed, it was difficult to judge clinical significance, and the evidence for all outcomes is very uncertain due to clinical heterogeneity, small sample sizes, incomplete reporting, and risk of bias. There is limited evidence to suggest that psychological interventions can reduce the need for medical contact or improve quality of life, and no studies reported adverse events. It was not possible to identify components of effective interventions and distinguish these from interventions showing no evidence of an effect due to substantial heterogeneity. Future investigations of evidence‐based psychological techniques should consider standardising outcomes to support cross‐comparison and better inform patient and policymaker decision‐making.


  • Open Access

    Financial Incentives for Smoking Cessation: Protocol for the Qualitative Evaluation of the Incentive to Quit (I2Q) Pilot

    by K. J. Sharrad, S. Perveen, T. Grammatopoulos, D. Phillips-Chantelois, K. V. Carson-Chahhoud

    Reducing tobacco usage has been identified as an urgent national health priority, being the leading cause of preventable death and disability in Australia. The Incentive to Quit (I2Q) pilot aims to reduce the harms associated with smoking and vaping by training health professionals on delivering brief smoking cessation advice, and providing eligible smokers/vapers with financial incentives, use of the Quitline counselling service, and pocket-sized resources with content tailored to help support quit attempts at different stages of the participant’s journey. A qualitative evaluation of the I2Q intervention will be undertaken throughout the program period via one-on-one interviews with a subset of health professionals and participants (smokers/vapers) of the I2Q program, along with key community stakeholders, to identify how the service can be improved. Interviews of approximately 45–60 minutes will be conducted either face-to-face or via telecommunication, and a moderator guide will be used to direct the interview. Interview transcripts will be coded through both inductive and deductive thematic analyses by two independent coders.

  • Open Access

    Mixed Reality Technology to Deliver Psychological Interventions to Adolescents With Asthma: Qualitative Study Using the Theoretical Framework of Acceptability

    by Kelsey Sharrad, Caitlin Martini, Andrew Tai, Nicola Spurrier, Ross Smith, Adrian Esterman, Ian Gwilt, Debra Sandford, Kristin Carson-Chahhoud

    Background: Interactive, mixed reality technologies such as augmented reality, virtual reality, and holographic technology may provide a novel solution to fast-track the translation of evidence into practice. They may also help overcome barriers to both mental health and asthma management service uptake, such as cost, availability of appointments, fear of judgment, and quality of care. Objective: This study aimed to investigate if mixed reality technology is an acceptable mechanism for the delivery of a component of cognitive and behavioral therapies for the management of elevated psychological distress among young people with asthma. Methods: To explore the perceived acceptability of these technologies, mixed reality tools were evaluated via qualitative, 1-on-1 interviews with young people with asthma and symptoms of psychological distress, parents/caregivers of young people with asthma and symptoms of psychological distress, and relevant health professionals. The Theoretical Framework of Acceptability was used for the deductive coding of the recorded interview transcripts. Results: This study enrolled the following participants: (1) 3 adolescents with asthma and symptoms of psychological distress with a mean age of 14 (SD 1.7) years; (2) 4 parents/caregivers of adolescents with asthma with a mean age of 55 (SD 14.6) years; and (3) 6 health professionals with a mean age of 40.8 (SD 4.3) years. A total of 4 constructs—experienced affective attitude, experienced effectiveness, self-efficacy, and intervention coherence—were coded in all participant transcripts. The most frequently coded constructs were experienced affective attitude and intervention coherence, which were reported a total of 96 times. The least frequently coded construct was anticipated opportunity cost, which was reported a total of 5 times. Participants were mostly positive about the mixed reality resources. However, some concerns were raised regarding ethicality, particularly regarding privacy, accessibility, and messaging. Participants noted the need for technology to be used in conjunction with face-to-face engagement with health professionals and that some patients would respond to this type of delivery mechanism better than others. Conclusions: These results suggest that mixed reality technology to deliver psychological interventions may be an acceptable addition to current health care practices for young people with asthma and symptoms of psychological distress. Trial Registration: Australia and New Zealand Clinical Trials Registry ACTRN12620001109998; https://anzctr.org.au/Trial/Registration/TrialReview.aspx?id=380427


  • Open Access

    An Augmented Reality Technology to Provide Demonstrative Inhaler Technique Education for Patients With Asthma: Interview Study Among Patients, Health Professionals, and Key Community Stakeholders

    by Antonia O'COnnor, Kelsey Sharrad, Charmaine King, Kristin Carson-Chahhoud

    Background: Many people with asthma use incorrect inhaler technique, resulting in suboptimal disease management and increased health service use. Novel ways of delivering appropriate instructions are needed. Objective: This study explored stakeholder perspectives on the potential use of augmented reality (AR) technology to improve asthma inhaler technique education. Methods: On the basis of existing evidence and resources, an information poster displaying the images of 22 asthma inhaler devices was developed. Using AR technology via a free smartphone app, the poster launched video demonstrations of correct inhaler technique for each device. In total, 21 semistructured, one‐on‐one interviews with health professionals, people with asthma, and key community stakeholders were conducted, and data were analyzed thematically using the Triandis model of interpersonal behavior. Results: A total of 21 participants were recruited into the study, and data saturation was achieved. People with asthma were confident with inhaler technique (mean score 9.17, SD 1.33, out of 10). However, health professionals and key community stakeholders identified that this perception was misguided (mean 7.25, SD 1.39, and mean 4.5, SD 0.71, for health professionals and key community stakeholders, respectively) and facilitates persistent incorrect inhaler use and suboptimal disease management. Delivering inhaler technique education using AR was favored by all participants (21/21, 100%), particularly around ease of use, with the ability to visually display inhaler techniques for each device. There was a strongly held belief that the technology has the capacity for improving inhaler technique across all participant groups (mean 9.25, SD 0.89, for participants; mean 9.83, SD 0.41, for health professionals; and mean 9.5, SD 0.71, for key community stakeholders). However, all participants (21/21, 100%) identified some barriers, particularly regarding access and appropriateness of AR for older people. Conclusions: AR technology may be a novel means to address poor inhaler technique among certain cohorts of patients with asthma and serve as a prompt for health professionals to initiate review of inhaler devices. A randomized controlled trial design is needed to evaluate the efficacy of this technology for use in the clinical care setting.


  • Open Access

    The modifiable biopsychosocial drivers of psychological distress for adolescents with asthma: Implications for Clinical Care

    by Kelsey J. Sharrad, Zoe A. Kopsaftis, Kristin V. Carson-Chahhoud, Helen M. Stallman